Kapanlagi.com - The pandemic of corona covid-19 virus is still not under control. Various efforts are still being made to reduce the transmission rate of the corona covid-19 virus. One of them is by continuing various research to find vaccines and drugs for this respiratory system disease. Recently, Universitas Airlangga (UNAIR) announced the discovery of a drug combination with the potential to counter corona covid-19.
The results of the discovery were announced on Friday (12/06) by Colonel Drs. Sunarwibowo, S.H., M.Hum., as the Chairman of the Stem Cell Research and Development Center at Universitas Airlangga, accompanied by Dr. dr. Purwati, SpPD. Here are some facts and reviews related to the drug combination with the potential to counter corona covid-19, as reported from the news.unair.ac.id website.
Â
Â
1. Combination of Drugs
(credit: pixabay)
From the source cited, K-PTI FINASIM mentions that there are five types of drugs believed to have the potential to combat the corona virus covid-19. The combinations of these five drugs are as follows.
1) Lopinavir/ritonavir with azithromycin
2) Lopinavir/ritonavir with doxycycline
3) Lopinavir/ritonavir with clarithromycin
4) Hydroxychloroquine with azithromycin
5) Hydroxychloroquine with doxycycline
2. Potential to Fight the Virus
(credit: pixabay)
Furthermore, the announcement also states that the combination of these five drugs is believed to be able to fight the virus. Regarding the dosage, each combined drug has a certain amount, which is 1/5 and 1/3 smaller than the dosage as a single drug. Therefore, the side effects of each drug are reduced.
3. Potential of Stem Cells
In the announcement, UNAIR researchers also conveyed that they have discovered the potential in stem cell research. In addition, Dr. Purwati also explained the existence of two formulas, namely Haematopotic Stem Cells (HSCs) and Natural Killer (NK) cells.
"From the challenge test results, it was found that after 24 hours, the SARS CoV2 virus isolate from Indonesia could be eliminated by these stem cells. Meanwhile, from the challenge test results on NK cells against the virus, it was found that after 72 hours, some of the virus could be inactivated by these NK cells," she explained.
Based on these two facts, the combination of these drugs is believed to have potential and will be effective enough to prevent and treat SARS CoV 2 virus attacks. In the future, Dr. Purwati hopes that these findings can be an alternative and recommendation for doctors, pharmaceutical industries, and the community to face the COVID-19 pandemic.
4. In the Production Process and Not Sold Freely
Dr. dr. Purwati, SpPD explained that currently the production of the drug is ongoing. In fact, hundreds have already been produced and are ready to be distributed to hospitals in need. Dr. dr. Purwati, SpPD also added that this drug will not be sold. One of the reasons is that this drug is the result of collaboration between UNAIR, BNPB, and the State Intelligence Agency.
Those are some of the facts related to the latest findings from Unair regarding the potential combination of drugs to counter the corona covid-19. Hopefully, this will be a way out of this pandemic.
(kpl/psp)
Disclaimer: This translation from Bahasa Indonesia to English has been generated by Artificial Intelligence.